|
GL261 cells
|
736.5 nM
|
CCK-8 assay
|
PMC11740939
|
|
Huh-7 cells
|
70 μg/mL
|
MTT assay
|
Download PDF
|
|
GM639
|
0.1 µM
|
assay
|
PMC3643584
|
|
HCT116
|
0.6–0.8 µM
|
assay
|
PMC3643584
|
|
RKO
|
0.6–0.8 µM
|
assay
|
PMC3643584
|
|
SW48
|
0.6–0.8 µM
|
assay
|
PMC3643584
|
|
HL-60
|
<0.1 µM
|
assay
|
PMC3643584
|
|
MCF7
|
nearly 10 µM
|
assay
|
PMC3643584
|
|
C26 cells
|
32.3 ± 2.6 μg/mL (12h), 30.8 ± 2.9 μg/mL (24h)
|
MTT assay
|
PMC6587349
|
|
HT29 cell line
|
15 mg/mL
|
MTT assays
|
PMC7151348
|
|
C26 cell line
|
18 mg/mL
|
MTT assays
|
PMC7151348
|
|
Hela cells
|
1450 nM (48 h), 987 nM (72 h)
|
Standard MTT method
|
PMC4679353
|
|
Hela cells
|
500 nM (48 h), 161 nM (72 h)
|
Standard MTT method
|
PMC4679353
|
|
LNCaP-FGC
|
0.03 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
HepG2
|
0.04 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
HeLa
|
0.04 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
MCF-7
|
0.05 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
DU145
|
0.04 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
PC-3
|
0.04 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
LO2
|
0.05 ± 0.01 μM
|
MTT method
|
PMC8650835
|
|
A549
|
268.2 nM
|
CCK-8 luminescence assay
|
PMC9805739
|
|
LLC
|
1278.0 nM
|
CCK-8 luminescence assay
|
PMC9805739
|
|
Panc-1
|
9.769 ± 0.362 µM
|
SRB method
|
PMC10024910
|
|
BxPC-3
|
0.388 ± 0.012 µM
|
SRB method
|
PMC10024910
|
|
HCT116
|
0.092–0.145 µM (24h), 0.039–0.065 µM (48h), 0.007–0.009 µM (
|
CellTiter 96®AQueous One Solution Cell Proliferation Assay (MTS) kit, non-linear regression and sigmoid dose-response curve using GraphPad Prism 6 software
|
Download PDF
|
|
HT-29
|
0.296–0.496 µM (24h), 0.038–0.056 µM (48h), 0.001–0.003 µM (
|
CellTiter 96®AQueous One Solution Cell Proliferation Assay (MTS) kit, non-linear regression and sigmoid dose-response curve using GraphPad Prism 6 software
|
Download PDF
|
|
SW620
|
0.016–0.028 µM (24h), 0.012–0.018 µM (48h), 0.002–0.003 µM (
|
CellTiter 96®AQueous One Solution Cell Proliferation Assay (MTS) kit, non-linear regression and sigmoid dose-response curve using GraphPad Prism 6 software
|
Download PDF
|
|
SW480 cells
|
72.01 ± 1.29 μg/mL
|
CCK8 assay
|
PMC11416794
|
|
NCI-N87
|
10.91 ± 11.12
|
MTT assay
|
Download PDF
|
|
SGC-791
|
19.27 ± 3.30
|
MTT assay
|
Download PDF
|
|
B-CPAP cells
|
8.98 mM
|
MTT assay
|
Download PDF
|
|
FTC-133 cells
|
8.52 mM
|
MTT assay
|
Download PDF
|
|
4T1 cells
|
0.50 µM (for BTC NPs, releasing CPT)
|
MTT assay
|
Download PDF
|
|
MCF-7 cells
|
0.63 µM (for BTC NPs, releasing CPT)
|
MTT assay
|
Download PDF
|
|
LN229
|
0.0079 µM
|
trypan blue dye exclusion assay, non-linear regression analysis using GraphPad Prism software
|
Download PDF
|
|
HT-29
|
0.0079 µM
|
trypan blue dye exclusion assay, non-linear regression analysis using GraphPad Prism software
|
Download PDF
|
|
MSTO-211H
|
0.0033 µM
|
trypan blue dye exclusion assay, non-linear regression analysis using GraphPad Prism software
|
Download PDF
|
|
MeT-5A
|
0.0078 µM
|
trypan blue dye exclusion assay, non-linear regression analysis using GraphPad Prism software
|
Download PDF
|
|
HCT116 cells
|
0.036 µM
|
MTT assay
|
Download PDF
|
|
A-549
|
0.016 μM
|
sulforhodamine B colorimetric assay
|
PMC4111373
|
|
DU-145
|
0.029 μM
|
sulforhodamine B colorimetric assay
|
PMC4111373
|
|
KB
|
0.037 μM
|
sulforhodamine B colorimetric assay
|
PMC4111373
|
|
KBvin
|
0.12 μM
|
sulforhodamine B colorimetric assay
|
PMC4111373
|
|
HOP-62
|
0.01 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
HCT-116
|
0.03 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
SF-539
|
0.01 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
UACC-62
|
0.01 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
OVCAR-3
|
0.22 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
SN12C
|
0.02 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
DU-145
|
0.01 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
MCF7
|
0.01 μM
|
NCI-60 screen (five-dose assay)
|
PMC3983348
|
|
NCM460 cells
|
564 nM
|
CCK8 assay
|
Download PDF
|
|
GBM-X6 cells
|
23 µM
|
luminescent cell viability assay, non-linear fit (log(inhibitor) vs. response—variable slope (four parameters))
|
Download PDF
|
|
TC-71
|
3 nM
|
Growth inhibition assays, cell counting using a CoulterCounter.
|
Download PDF
|
|
CADO-ES1
|
2 nM
|
Growth inhibition assays, cell counting using a CoulterCounter.
|
Download PDF
|
|
TC-71
|
5.5 nM
|
Colony formation (clonogenic) assays.
|
Download PDF
|
|
CADO-ES1
|
6.0 nM
|
Colony formation (clonogenic) assays.
|
Download PDF
|
|
MX-1
|
1700 nM
|
Standard quantitative colorimetric MTT assay.
|
PMC4096217
|
|
MCF-7
|
65.1 nM
|
Standard quantitative colorimetric MTT assay.
|
PMC4096217
|
|
ID8
|
474 nM
|
Standard quantitative colorimetric MTT assay.
|
PMC4096217
|
|
L1210FR
|
510 nM
|
Standard quantitative colorimetric MTT assay.
|
PMC4096217
|
|
WI38
|
786 nM
|
Standard quantitative colorimetric MTT assay.
|
PMC4096217
|
|
HT-29 cells
|
79,024 μg/mL
|
CCK-8 assays
|
PMC6634269
|
|
MCF-7
|
11.12 µM
|
CCK-8
|
PMC6304248
|
|
HCT-116
|
5.50 µM
|
CCK-8
|
PMC6304248
|
|
LLC
|
59.11 µM
|
CCK-8
|
PMC6304248
|
|
S180
|
12.26 µM
|
CCK-8
|
PMC6304248
|
|
4T1 cells
|
6.35 μg/mL
|
MTT assay
|
PMC6842288
|
|
Rb Y79 total cells
|
110.4
|
MTT assay
|
PMC8606840
|
|
Rb Y79 CSCs
|
230.3
|
MTT assay
|
PMC8606840
|
|
Rb Y79 non-CSCs
|
144.4
|
MTT assay
|
PMC8606840
|
|
U87 cells
|
3.85 µM
|
MTS assay
|
Download PDF
|
|
SiHa cells
|
1µM
|
cell counting
|
Download PDF
|
|
SiHa cells (PLK1 silenced)
|
<0.1 µM
|
cell counting
|
Download PDF
|
|
Colospheres derived from CR-LRB-018P xenografts
|
23.8 ± 5.8 mM
|
Lactate dehydrogenase and water-soluble tetrazolium assays, followed by sigmoidal dose-response analysis using the Hill fitting equation in Prism 4 software.
|
PMC3668460
|
|
Colospheres derived from CR-IC-004M xenografts
|
424.7 ± 93.7 mM
|
Lactate dehydrogenase and water-soluble tetrazolium assays, followed by sigmoidal dose-response analysis using the Hill fitting equation in Prism 4 software.
|
PMC3668460
|
|
786-O
|
3.7E-9 M
|
MTT assays
|
Download PDF
|
|
HT29
|
2.2E-8 M
|
MTT assays
|
Download PDF
|
|
NCI-H292
|
3.8E-9 M
|
MTT assays
|
Download PDF
|
|
SUM149PT
|
3.8E-9 M
|
MTT assays
|
Download PDF
|
|
FaDu
|
9856 ng/mL
|
CellTiter96 Aqueous One Solution Cell Proliferation Assay, relative absorbances at 490 nm
|
Download PDF
|
|
HT-29 cells
|
0.03 μM
|
CCK-8 assay
|
Download PDF
|
|
A549 cells
|
1.21 mM
|
Analysis of Spot Intensity of AcGFP in each cell
|
Download PDF
|
|
OCUM-2M
|
2.8 nM
|
MTT assay
|
PMC3833223
|
|
OCUM-2M/SP
|
29.5 nM
|
MTT assay
|
PMC3833223
|
|
OCUM-2D
|
7.7 nM
|
MTT assay
|
PMC3833223
|
|
OCUM-2D/SP
|
19.0 nM
|
MTT assay
|
PMC3833223
|
|
OCUM-2MD3
|
5.4 nM
|
MTT assay
|
PMC3833223
|
|
OCUM-2MD3/SP
|
11.8 nM
|
MTT assay
|
PMC3833223
|
|
HeLa cells
|
2.55 µM
|
MTT assay
|
PMC6177376
|
|
HeLa
|
1 µM
|
MTT assay
|
PMC6141119
|
|
MCF7 cells (SN38 solution)
|
0.37 μM
|
CCK-8 assay, absorbance read at 450 nm, IC50 calculated using a four-parameter logistic function standard curve analysis of the dose response.
|
PMC5955381
|
|
MIA PaCa-2
|
0.5 μM
|
MTT assay
|
Download PDF
|
|
PANC-1
|
0.3 μM
|
MTT assay
|
Download PDF
|
|
HT29 cells
|
0.56 ±0.01 µg/mL
|
MTT assay
|
PMC5125756
|
|
mouse medulloblastoma cells (144-4)
|
CPT-11: 0.18 – 17.5 μM; SN-38: 0.2-2.2 nM
|
WST-1 or Guava ViaCount assay
|
PMC4149468
|
|
Daoy cells
|
CPT-11: 41 μM; SN-38: 25.9 nM
|
WST-1 or Guava ViaCount assay
|
PMC4149468
|
|
UW228 cells
|
CPT-11: 17.5 μM; SN-38: 2.2 nM
|
WST-1 or Guava ViaCount assay
|
PMC4149468
|
|
3T3 cells infected with T. cruzi Tulahuen strain
|
0.205 ± 0.012 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi Y strain
|
0.46 ± 0.029 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi G strain
|
0.28 ± 0.13 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi CL strain
|
0.14 ± 0.01 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi Tulahuen strain
|
0.16 ± 0.015 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi Y strain
|
0.37 ± 0.15 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi G strain
|
0.22 ± 0.002 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
3T3 cells infected with T. cruzi CL strain
|
0.093 ± 0.004 µM
|
Image-based assays using Hoechst 33342 and HCS CellMask Green staining, Phenix confocal imaging, and analysis of infected cells containing ≥5 parasites per cell.
|
Download PDF
|
|
BT20 cells
|
1.334 ±0.303 μg/mL
|
CCK-8 assay
|
Download PDF
|
|
MDA-MB-231 cells
|
0.219 ±0.171 μg/mL
|
CCK-8 assay
|
Download PDF
|
|
4T1 cells
|
0.012 ±0.006 μg/mL
|
CCK-8 assay
|
Download PDF
|
|
U87
|
10.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
A172
|
10.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
LN443
|
10.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
U118
|
10.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK72 (adherent culture)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK72 (neurosphere)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK262 (adherent culture)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK262 (neurosphere)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK429 (neurosphere)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
SK660 (neurosphere)
|
30.00 μM
|
Alamar Blue viability assay
|
Download PDF
|
|
C6 cells
|
27.0 ng/mL
|
MTT assay
|
Download PDF
|
|
MCF-7
|
381 nM (3 days), 58.5 nM (5 days)
|
MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) colorimetric assay
|
Download PDF
|
|
CaCo-2
|
44.4 nM
|
MTT assay, colorimetric analysis at 570 nm
|
PMC11579335
|
|
SW480
|
1.7 nM
|
MTT assay, colorimetric analysis at 570 nm
|
PMC11579335
|
|
A549 cell lines
|
135.8339 µl/ml
|
MTT assay
|
Download PDF
|
|
HT29 cell lines
|
46.42733 µl/ml
|
MTT assay
|
Download PDF
|
|
HeLa cell lines
|
39.6765 µl/ml
|
MTT assay
|
Download PDF
|
|
L929 cell lines
|
336.68574 µl/ml
|
MTT assay
|
Download PDF
|
|
MGC803
|
0.74 µM
|
MTT assay
|
Download PDF
|
|
GS1
|
0.79 µM
|
MTT assay
|
Download PDF
|
|
SW620
|
0.69 µM
|
MTT assay
|
Download PDF
|
|
NCM460
|
0.81 µM
|
MTT assay
|
Download PDF
|
|
HepG2
|
0.89 µM
|
MTT assay
|
Download PDF
|
|
L02
|
0.93 µM
|
MTT assay
|
Download PDF
|
|
MCF7
|
0.53 µM
|
MTT assay
|
Download PDF
|
|
Hela
|
0.36 µM
|
MTT assay
|
Download PDF
|
|
Caco-2 cells
|
16.2 ± 2.9 µM
|
MTT assay
|
Download PDF
|
|
HT-29 cells
|
13.1 ± 2.1 µM
|
MTT assay
|
Download PDF
|
|
H460 Cells (2D)
|
2.59 mM
|
alamarBlue Hassay
|
Download PDF
|
|
H460 Cells (3D)
|
69.72 mM
|
alamarBlue Hassay
|
Download PDF
|
|
A549 Cells (2D)
|
1.36 mM
|
alamarBlue Hassay
|
Download PDF
|
|
A549 Cells (3D)
|
89.74 mM
|
alamarBlue Hassay
|
Download PDF
|
|
H1650 Parental Cells (2D)
|
4.48 mM
|
alamarBlue Hassay
|
Download PDF
|
|
H1650 Parental Cells (3D)
|
51.84 mM
|
alamarBlue Hassay
|
Download PDF
|
|
H1650 Stem Cells (2D)
|
7.49 mM
|
alamarBlue Hassay
|
Download PDF
|
|
H1650 Stem Cells (3D)
|
95.46 mM
|
alamarBlue Hassay
|
Download PDF
|
|
HCT116
|
30 ±1.49 μM
|
MTT assay
|
Download PDF
|
|
SW480
|
30 ±2.64 ng/μl
|
MTT assay
|
Download PDF
|
|
HCT116-R1
|
55 ±2.06 ng/μl
|
MTT assay
|
Download PDF
|
|
HCT116-R2
|
134 ±2.03 ng/μl
|
MTT assay
|
Download PDF
|
|
HCT116-R3
|
290 ±2.45 ng/μl
|
MTT assay
|
Download PDF
|
|
HCT116-R4
|
320 ±1.97 ng/μl
|
MTT assay
|
Download PDF
|
|
SW480-R1
|
60 ±6.57 ng/μl
|
MTT assay
|
Download PDF
|
|
SW480-R2
|
80 ±4.08 ng/μl
|
MTT assay
|
Download PDF
|
|
SW480-R3
|
220 ±2.46 ng/μl
|
MTT assay
|
Download PDF
|
|
SW480-R4
|
260 ±1.11 ng/μl
|
MTT assay
|
Download PDF
|
|
HCT116-R3 (transfected with pre-miR-3664-3p)
|
25 ±2.37 ng/μl
|
MTT assay
|
Download PDF
|
|
SW480-R3 (transfected with pre-miR-3664-3p)
|
20 ±2.72 ng/μl
|
MTT assay
|
Download PDF
|
|
HT29
|
3 nM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
HCT116
|
>300 nM
|
Sulforhodamine B (SRB) assay
|
Download PDF
|
|
BL-2
|
0.02 ± 0.01 μM
|
Viability assay
|
Download PDF
|
|
A2780
|
0.08 ± 0.02 μM
|
Viability assay
|
Download PDF
|
|
DU-145
|
0.03 ± 0.01 μM
|
Viability assay
|
Download PDF
|
|
LS174T
|
0.3 mM
|
alamarBlue assay, dose-response curves, Median-Effect Principle, CompuSyn software
|
Download PDF
|
|
LS174T
|
44 mM
|
alamarBlue assay, dose-response curves, Median-Effect Principle, CompuSyn software
|
Download PDF
|
|
N2A
|
0.03 mM
|
MTT assay
|
PMC3282612
|
|
PANC-1
|
1.442 µmol/L
|
CellTiter-Blue cell viability assay
|
PMC12103773
|
|
MIAPaCa-2
|
1.198 µmol/L
|
CellTiter-Blue cell viability assay
|
PMC12103773
|
|
ES-2 monolayer
|
<0.01 μM
|
MTS assay
|
Download PDF
|
|
ES-2 spheroids
|
5.2 μM
|
MTS assay
|
Download PDF
|
